In the central nervous system (CNS),
insulin resistance (I/R) can cause defective neurite outgrowth and neuronal cell death, which can eventually lead to cognitive deficits. Recent research has focused on the relationship between I/R and the
cognitive impairment caused by
dementia, with the goal of developing treatments for
dementia.
Insulin signal transduction mediated by
insulin receptor substrate (IRS-1) has been thoroughly studied in the CNS of patients with I/R. In the present study, we investigated whether the impairment of IRS-1-mediated
insulin signaling contributes to neurite outgrowth and neuronal loss, both in mice fed a high-fat diet and in mouse
neuroblastoma (Neuro2A) cells. To investigate the changes caused by the inhibition of IRS-1-mediated
insulin signaling in the brain, we performed
Cresyl Violet staining and immunochemical analysis. To investigate the changes caused by the inhibition of IRS-1-mediated
insulin signaling in
neuroblastoma cells, we performed Western blot analysis, reverse transcription-PCR, and immunochemical analysis. We show that the deactivation of IRS-1-mediated
insulin signaling can inhibit neuronal outgrowth and aggravate neuronal cell death in the
insulin-resistant CNS. Thus, IRS-1-mediated
insulin signal transduction may be an important factor in the treatment of
cognitive decline induced by I/R.